Introduction
Musculoskeletal tissue engineering (TE) including regenerative systems for articular cartilage, meniscal cartilage, ligament and bone provides a potential solution for osteoporosis, osteoarthritis, trauma-induced injuries and osteochondral lesions.
TE involves the in vitro seeding and attachment of human cells onto a scaffold, which provides cells with a suitable microenvironment to proliferate, migrate and differentiate into a speci ic tissue type 1 . It is therefore apparent that the design of this scaffold is critical to the success of TE. Approaches in scaffold design must be able to recreate the hierarchical structure of the target tissue. In this case, 'hierarchical' refers to the fact that features of the scaffold at length scales from the nanometre to millimetre, centimetre and metre levels should match the intended tissue and they will determine how well the scaffold functions in meeting the con licting requirements of bioactivity and appropriate mechanical and mass transport (permeability and diffusion) needs 2 . In the case of bone, the nano-scale characteristics (collagen type, crosslinking, hydroxyapatite [HAp] stoichiometry) play a role in cell and mineral binding, while the micrometre-scale porosity helps with cell migration and vascularisation, and macroscale organisation (osteons, osteoids and Haversian canals) provides the mechanical anisotropy of long bones 3 . This review will focus on the need for such hierarchical control of scaffold properties at molecular, microscopic, mesoscopic and macroscopic levels for bone TE.
Bone architecture
Biological organisms such as bone have evolved to produce hierarchical threedimensional structures 4 . Replicating these complex hierarchical structures for the purpose of their replacement requires clear understanding of each level. Figure 1 illustrates the hierarchical structure of bone.
On the macroscopic level, the two major types of bony tissue (trabecular and cortical) are of different anatomical shapes. Although they are of similar composition their distinctive hierarchical structuring gives them a very different set of properties (e.g. mechanical properties).
On a mesoscopic level, as illustrated in Table 1 , having a highly porous structure (90% porosity 6 ), trabecular bone consists of plates (trabeculae, 100-300 μm thick with spacing of 300-1500 μm between adjacent trabeculae 7 ) , located next to small cavities containing red bone marrow 3 . This can be used in designing bone-like collagen-HAp composite materials whose properties are similar to that of trabecular bone (e.g. the unidirectionally orientated collagen ibres) 8 . On the other hand, having only 10% porosity, cortical bone 6 comprises osteons, which are bundles of mineralised collagen ibres of about 200 μm in diameter and 10.0 to 20.0 mm long 7 , positioned parallel to each other 8 . The central canal (Haversian canal) contains blood vessels 7, 12 , while small channels (canaliculi) extending outward to the canal provide microcirculation of blood and nutrients to the cells 3, 6, 7 . In this system, cells are not found beyond 200 μm of a blood supply and oxygen 14 . This has important implications for designing the scaffolds at micro-and meso-scales, where the porosity and channels help with cell migration and vascularisation.
On the microscopic and molecular levels, osteons create the extracellular matrix (ECM) of bone: a composite of an organic phase reinforced by an inorganic phase. The organic matrix primarily consists of collagen (Type I). This matrix is mineralised by a calcium phosphate described as carbonate-substituted HAp 15 . Each of these constituents exists at different scales from nano-to micro-levels with different orientations 16 .
The need for hierarchical scaffolds in bone tissue engineering Licensee It has been well established that bone cells are strongly in luenced by topography in vitro; since cell cytoskeleton and ECM proteins bind directly through cell receptors, cells sense and respond to the physiochemical properties of the matrix by gene expression and protein production 3, 17, 18 . Therefore, the characteristics of a scaffold at molecular (e.g. collagen type and HAp stoichiometry) and microscopic (e.g. microstructure and porosity) levels can affect the cell behaviour.
Drawing on the structure of bone, the following sections illustrate the control over hierarchical structure of a scaffold for bone TE.
Discussion
The authors have referenced some of their own studies in this review. These referenced studies have been conducted in accordance with the Declaration of Helsinki (1964) and the protocols of these studies have been approved by the relevant ethics committees related to the institution in which they were performed. All human subjects, in these referenced studies, gave informed consent to participate in these studies.
Molecular level
At the molecular level of a biomimetic collagen-HAp scaffold, type of collagen, its cross-linking and stoichiometry of HAp need to be tailored in a way that they mimic bone 3 .
Collagen
Collagen has a large number of ligands suitable to promote cell attachment and proliferation and delivery of growth factors 9 . Collagen ), consists of osteons (parallel cylindrical units) that are oriented in longitudinal direc on in long bones 7, 10, 11 Highly porous (90% porosity 6 ) honeycomb structure with numerous small bone trusses (trabeculae) interconnected; tend to orient along the principal stress direc ons 6, 7, 10, 12 Pore size
Haversian canals, with a cross-sec onal area of 2500-12,000 μm 2 (0.028-0.061 mm diameter) 13 In order of 1 mm in diameter 13 Propor on (varies according to the loca on) 80% of total mass Type I offers natural binding sites such as the Arg-Gly-Asp (RGD) and the Asp-Gly-Glu-Ala (DGEA) peptide sequence that promote the adhesion of osteoblasts and ibroblasts 19 . At its molecular level, collagen has three hierarchical structures: primary, secondary and tertiary structures 20 . The primary structure of collagen denotes a sequence of amino acids residues (X-Y-Gly) where frequently X is proline and Y is hydroxyproline. These blocks of amino acids form a helical polypeptide chain called an α-chain where their secondary structure refers to the local con iguration of these individual chains. The tertiary structure signi ies the large-scale folding and helicity of these chains, which form the fundamental unit of collagen molecule 20 . Regardless of their type, each collagen molecule, known as tropocollagen, is composed of three α-chains forming a triple helix.
Type I tropocollagen, which is the dominant type of collagen in bone, is a triple-helix of two α1(I) and one α2(I) chains (approximately 300 nm in length and 1.5 nm in diameter), while collagen Type II, which is the dominant type in cartilage, consists of three α1(II) chains 21, 22 . These isolated collagen triple helices are referred to as 'monomeric', which may be telopeptide-de icient (atelocollagen) or telopeptide-intact (tropocollagen) 23 . These triple helices self-assemble/ polymerise to form collagen ibrils 24 (see Figure 2) , which are stabilised by speci ic covalent cross-links between collagen molecules 25 . The HAp crystals are deposited parallel to the collagen ibres and predominantly occupy the gaps between them. Bundles of microfibrils form larger fibrils, which in turn form still larger fibres 9 . One of the important implications of this structure is that currently the majority of collagen materials are extracted from animal tissue derivatives, con irming the issue of collagen antigenicity. Antigenic determinants of collagen may be helical, central or terminal; hence atelocollagens devoid of these p-determinants (a region sensitive to antibodies near the C-terminus of both types of α-chains) are usually the preferred form of collagen for biomimetic bone TE 23, 27 , which can be polymerised in vitro, as shown in Figure 3 .
Cross-linking
The ordered structure of collagen arises from the interactions between hydrophobic and polar groups of the molecules, which are enough to assemble the ibrils; however, they do not give the structure much mechanical stability. This is achieved by the formation of covalent bonds, that is, cross-linking, which can be intra-or inter-molecular 9 . A different degree of cross-linking allows the scaffold degradation time to be tailored as it improves both the mechanical properties and resistance to enzymatic degradation 28 . The methods of cross-linking may be described as chemical (GTA, EDC/ NHS), physical (DHT, UV) or biological (ENZ). Some of these methods, however, have adverse effects (e.g. DHT causes slight denaturation of collagen or GTA have signi icant cytotoxic effects) on attachment and proliferation of cells on collagen-based biomedical implants.
Consequently, treatment with 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide/N-hydroxysuccinimide (EDC/NHS) has become a favourable method for collagen crosslinking as it has been shown to have good biocompatibility, increase the 
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Typical
HAp
At the molecular level, HAp is present in the form of plates or needles that are 40 to 60 nm long, 20 nm wide and 1.5 to 5 nm thick. They orient themselves such that the larger dimension of crystals is along the long axis of the collagen ibre 12 . Bone Hap has the stoichiometric formula of Ca 10 (PO 4 ) 6 OH 2 . The calcium-phosphorus molar ratio varies due to presence of some impurities, including carbonate ions in the lattice, which may be present up to 8wt%. The carbonate ions can substitute for hydroxide (Type A substitution) or for phosphate ion (Type B substitution), with a consequent substitution of sodium for calcium ions to maintain charge balance. This ionic substitution is important for destabilising the crystal lattice and making HAp easier to resorb in the body. HAp must be resorbable for the body to be able to remodel bone. Stoichiometric HA has often been used as a scaffold, but reports indicate that it has slow degradation 15 . The particle size of HAp also has in luence on the response of osteogenic cells. In particular, it has been shown smaller particles aid cellular proliferation 9, 29 . HAp particles are shown within the collagenous matrix in Figure 4 in a collagen-HAp scaffold fabricated by freeze-drying.
Microscopic level
The morphology of bone is comprised of trabecular bone, creating a porous environment (50%-90%) and pore sizes at the order of 1 mm in diameter, with cortical bone surrounding it. Cortical bone has a solid structure with a series of voids (e.g. Haversian canals), which results in 3% to 12% porosity 13 . The microscale features of bone provide a channel for cell migration, nutrient delivery and vascularisation.
Pores and their interconnectivity are indispensable for tissue formation. The combination of multi-scaled pore size and porosity into one structure has been shown to be an effective solution for yielding improved overall performances of TE scaffolds 30 . While macroporosity (pore size 450 μm) has a strong impact on osteogenicity, microporosity (pore size 10-100 μm) and pore wall roughness are important factors as well 3, 13 . The most common fabrication methods used to recreate the microscale porosity and special organisation of native bone in a biomaterial are rapid prototyping (e.g. solid free form), salt leaching, gas foaming, phase separation, freeze-drying and sintering depending on the scaffold material 1, 13 . Following a biomimetic approach to TE, choosing a natural polymer (speci ically collagen) can limit the aforementioned techniques considerably. Natural polymers are protein-based, which means they are susceptible to temperature (denaturation above 40) and pH; therefore, the techniques using high temperature or chemicals are not suitable 28 . Freeze-drying/lypholisation is one of the methods frequently used to generate microporosity in natural scaffolds. Here, a solution of collagen is frozen and then freeze-dried. The pores are negative replicate of ice crystals that are formed during freezing, forcing collagen into interstitial spaces, which are then removed by freeze-drying.
Here, the pore size can be controlled by freezing temperature and collagen concentration of scaffold. The former includes the degree of under-cooling: the larger the undercooling is, the smaller are the ice crystals formed; thus, we end up with a scaffold with smaller pore sizes 31 . A lower inal temperature of freezing yields faster ice crystal nucleation and smaller pores 32 . With regards to collagen concentration, it is shown to affect the cohesion/viscosity of the solution during freezing by limiting the rate of diffusion and ice crystal growth, thus decreasing the pore sizes [32] [33] [34] . Another method to vary the scaffold pore size might be through the introduction of annealing during lyophilisation, which increases the pore size by increasing the rate of crystal growth during the freezing phase 35 . Figure 6 illustrates the parameters affecting pore size in freeze-drying.
Mescoscopic level
Bone formation requires high rates of mass transfer during cultivation 37 , and human body supplies it with adequate amount of chemicals via blood vessels 1 . In fact, in vivo, cells are no more than 100 μm away from a capillary for supply of oxygen and nutrients 1, 37 . So far, it has been shown that the hierarchy at the microscopic level provides cells with the interconnected porosity they require to attach, migrate, proliferate, receive oxygen and nutrients and dispose of waste products. However, the pores may not necessarily be interconnected. Even if they are fully interconnected with the required dimensions, metabolically active cells cannot migrate deep into the scaffold due to diffusion constraints of oxygen and nutrients; only cells close to the surface are able to survive, and, due to mineralisation at the periphery of the scaffold, they effectively block further diffusion and mass transfer to the interior of the scaffold (see Figure 7 ), leading to growth of only thin cross-sections of tissue (<500 μm) 1, 38, 39 . Therefore, to overcome diffusionrelated limitations, two general methods can be used. One approach is to increase the effective diffusive length, so that cells go deeper into the scaffold. The diffusion distance can be increased by increasing porosity, using hydrogels or specialised carriers (e.g. per luorocarbons), which increase the concentration of oxygen in the medium.
Another approach is to utilise convective transport (perfusion) to carry nutrients/oxygen closer to the cells.
Perfusion can occur either in vivo, through the cardiovascular system, or in vitro, through a perfusion bioreactor 40 . In both cases, employing pre-vascularised constructs with microchannels has the potential to enhance perfusion and thus vascularisation 15, 40 . In fact, it has been shown that a vascular network of microvessels were formed in vivo in channelled collagen scaffolds after 2 weeks, while this was absent in non-channelled scaffolds 39 . Solid free form (SFF) 1 and microfabrication techniques, known as micro-electromechanical systems (MEMS), and a combination of SFF, microreplication and freeze-drying techniques have been used to produce scaffolds with channels 41 . Figure 8 shows a collagen scaffold with channels fabricated by freeze-drying.
Macroscopic level
The tissue-engineered structures will often need to be produced with complex three-dimensional anatomical shapes 2 . Therefore, the last level of hierarchy requires a processing method for scaffolds to replicate the anatomical shape of the tissue with the ability to be tailored to individual patients, while maintaining the hierarchical design at different levels.
Solvent casting and particulate leaching phase separation in combination with freeze-drying or critical point drying and SFF has been used to produce TE scaffolds 42 . One of the most promising methods is SFF, where voxel data of anatomical structures are acquired with computerised tomography (CT) or magnetic resonance imaging to design a mould for creating a patient-tailored scaffold. The mould is then manufactured using a 3D phase-change printer into which a dispersion of collagen with or without HAp is cast and frozen. The scaffold is then removed by dissolving the mould and it is then critical-point-dried 43 .
Conclusion
Hierarchical design of a scaffold has the potential to mimic the structure of highly complex tissues such as bone and create templates most suitable for TE. In has been discussed that how controlling the structure of a bone scaffold during manufacturing at each level of hierarchy can help with such design. At molecular level, selecting the right type of collagen (Type-I monomeric collagen)-HAp scaffold with a suitable stoichiometry and cross-linking improves the bioactivity, degradation and mechanical properties. At microscopic level, pore size and porosity affect cell response and mechanical properties and can be tailored by using a suitable fabrication method and varying the parameters. At the mesoscopic level, incorporation of channels enhances cell in-growth and vascularisation, and at macroscopic level, engendering anatomical-shaped scaffold using methods such as SFF can produce patient-tailored scaffolds.
